HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 11, Pages e113031
Publisher
Public Library of Science (PLoS)
Online
2014-11-15
DOI
10.1371/journal.pone.0113031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Finding a Cure for HIV: Much Work to Do
- (2014) Sharon R. Lewin ANNALS OF INTERNAL MEDICINE
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Economic Savings Versus Health Losses: The Cost-Effectiveness of Generic Antiretroviral Therapy in the United States
- (2013) Rochelle P. Walensky et al. ANNALS OF INTERNAL MEDICINE
- Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United States
- (2013) Paul G. Farnham et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Combined approaches for HIV cure
- (2013) David M. Margolis et al. Current Opinion in HIV and AIDS
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
- (2013) Asier Sáez-Cirión et al. PLoS Pathogens
- Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population
- (2012) Alison J. Rodger et al. AIDS
- Development of a Population-Based Cost-Effectiveness Model of Chronic Graft-Versus-Host Disease in Spain
- (2012) Carlos Crespo et al. CLINICAL THERAPEUTICS
- High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD
- (2012) Fiona L. Dignan et al. CLINICAL TRANSPLANTATION
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM
- (2011) Femke A.E. Lambers et al. AIDS
- Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand
- (2011) Pattara Leelahavarong et al. BMC PUBLIC HEALTH
- Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer
- (2011) Laura J. Havrilesky et al. CANCER
- Dramatic Decline in the HIV-1 RNA Level Over Calendar Time in a Large Urban HIV Practice
- (2011) R. D. Moore et al. CLINICAL INFECTIOUS DISEASES
- Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies
- (2011) Dragana Stamatovic et al. Vojnosanitetski Pregled
- Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma: Figure 1
- (2010) Shannon A. Kavanaugh et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada
- (2010) Keri N. Althoff et al. CLINICAL INFECTIOUS DISEASES
- Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte dʼIvoire
- (2010) Eugène Messou et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial
- (2009) Allison Martin et al. CLINICAL INFECTIOUS DISEASES
- HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost‐Effectiveness
- (2009) A. David Paltiel et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now